SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4.71 |
| Enterprise Value ($M) | 0.96 |
| Book Value ($M) | 4.07 |
| Book Value / Share | 0.62 |
| Price / Book | 1.16 |
| NCAV ($M) | 3.08 |
| NCAV / Share | 0.47 |
| Price / NCAV | 1.53 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.24 |
| Return on Assets (ROA) | -1.97 |
| Return on Equity (ROE) | -2.16 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.16 |
| Current Ratio | 4.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.06 |
| Assets | 5.04 |
| Liabilities | 0.98 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -8.28 |
| Net Income | -13.20 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.92 |
| Cash from Investing | 0.00 |
| Cash from Financing | 7.85 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | 101.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,485 | 17,905 | 25.05 | |
| 900 | 6,178 | 14.57 | |
| 4,408 | 16,046 | 27.47 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACB – Aurora Cannabis Inc. | ACHV – Achieve Life Sciences, Inc. |
| ACXP – Acurx Pharmaceuticals, Inc. | ADTX – Aditxt, Inc. |
| ADVM – Adverum Biotechnologies, Inc. |
Financial data and stock pages provided by
Fintel.io